TY - JOUR
T1 - Advancing social and economic development by investing in women's and children's health
T2 - A new Global Investment Framework
AU - Stenberg, Karin
AU - Axelson, Henrik
AU - Sheehan, Peter
AU - Anderson, Ian
AU - Gülmezoglu, A. Metin
AU - Temmerman, Marleen
AU - Mason, Elizabeth
AU - Friedman, Howard S.
AU - Bhutta, Zulfiqar A.
AU - Lawn, Joy E.
AU - Sweeny, Kim
AU - Tulloch, Jim
AU - Hansen, Peter
AU - Chopra, Mickey
AU - Gupta, Anuradha
AU - Vogel, Joshua P.
AU - Ostergren, Mikael
AU - Rasmussen, Bruce
AU - Levin, Carol
AU - Boyle, Colin
AU - Kuruvilla, Shyama
AU - Koblinsky, Marjorie
AU - Walker, Neff
AU - De Francisco, Andres
AU - Novcic, Nebojsa
AU - Presern, Carole
AU - Jamison, Dean
AU - Bustreo, Flavia
N1 - Funding Information:
The WHO and the Partnership for Maternal, Newborn, and Child Health (PMNCH) acknowledges the financial support received from all of its donors to date in 2013, whose support enabled the development of this article through direct funding, or through funding of other WHO and PMNCH work streams that informed ideas presented in this report. Furthermore, direct funding for the Investment Framework analysis, including a meeting of the Study Group, was provided by the Governments of Norway and Italy. PMNCH acknowledges financial support received from the following donors in 2013 (in alphabetical order): Government of Australia, Bill & Melinda Gates Foundation, Government of Canada, MacArthur Foundation, Government of the Netherlands, Government of Norway, Government of Sweden, Government of the UK, Government of the USA, and the World Bank.
Funding Information:
PH is employed by the GAVI Alliance. DJ's research at the University of Washington is funded by a grant from the Bill & Melinda Gates Foundation. During the period from October, 2012, to December, 2013, DJ was co-Chair and Study Director for The Lancet Commission on Investing in Health and in this capacity declares project funding from the Bill & Melinda Gates Foundation. He also declares support from GlaxoSmithKline to participate in a January 2012 consultative meeting of the advisory group for evaluating economic models for use of the RTS,S malaria vaccine.
PY - 2014
Y1 - 2014
N2 - A new Global Investment Framework for Women's and Children's Health demonstrates how investment in women's and children's health will secure high health, social, and economic returns. We costed health systems strengthening and six investment packages for: maternal and newborn health, child health, immunisation, family planning, HIV/AIDS, and malaria. Nutrition is a cross-cutting theme. We then used simulation modelling to estimate the health and socioeconomic returns of these investments. Increasing health expenditure by just $5 per person per year up to 2035 in 74 high-burden countries could yield up to nine times that value in economic and social benefits. These returns include greater gross domestic product (GDP) growth through improved productivity, and prevention of the needless deaths of 147 million children, 32 million stillbirths, and 5 million women by 2035. These gains could be achieved by an additional investment of $30 billion per year, equivalent to a 2% increase above current spending.
AB - A new Global Investment Framework for Women's and Children's Health demonstrates how investment in women's and children's health will secure high health, social, and economic returns. We costed health systems strengthening and six investment packages for: maternal and newborn health, child health, immunisation, family planning, HIV/AIDS, and malaria. Nutrition is a cross-cutting theme. We then used simulation modelling to estimate the health and socioeconomic returns of these investments. Increasing health expenditure by just $5 per person per year up to 2035 in 74 high-burden countries could yield up to nine times that value in economic and social benefits. These returns include greater gross domestic product (GDP) growth through improved productivity, and prevention of the needless deaths of 147 million children, 32 million stillbirths, and 5 million women by 2035. These gains could be achieved by an additional investment of $30 billion per year, equivalent to a 2% increase above current spending.
UR - http://www.scopus.com/inward/record.url?scp=84898053131&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84898053131&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(13)62231-X
DO - 10.1016/S0140-6736(13)62231-X
M3 - Comment/debate
C2 - 24263249
AN - SCOPUS:84898053131
SN - 0140-6736
VL - 383
SP - 1333
EP - 1354
JO - The Lancet
JF - The Lancet
IS - 9925
ER -